Kallyope
Focusing on Big Health Challenges That Matter
New York, United States · Founded 2015 · $487.2M raised
- Headquarters
- New York, New York
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- kallyope.com
- Total Funding
- $487.2M
- Last Round
- $8.2M GrantMay 2023
- Rounds
- 6
About
Founded in 2015 by world-leading neuroscientists, Kallyope uses its Klarity platform to target the gut-brain axis for neurological and metabolic diseases. The late-stage pipeline includes acute migraine treatments and novel metabolism programs entering clinical studies in 2026.
Summary
Kallyope is a Biotech company based in New York, United States, founded in 2015. It has raised $487.2M in total across 6 rounds, most recently a $8.2M Grant round in May 2023. Investors include Bill & Melinda Gates Foundation, Lux Capital and Polaris Partners.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
May 2023
Sign up to see all 6 rounds
Series A through Grant — per-round amounts, valuations, and who invested in each round.
Investors
Bill & Melinda Gates Foundation
3 rounds
Lux Capital
3 rounds
Polaris Partners
3 rounds
Casdin Capital
2 rounds
Two Sigma Ventures
2 rounds
Mubadala Investment Company
1 round
The Column Group
1 round
Greenspring
1 round
Alexandria Venture Investments
3 rounds
Illumina Ventures
3 rounds
Euclidean Capital
2 rounds
DNS Capital
1 round
Hartford Healthcare Endowment
1 round
Parkwood
1 round
Tao Capital Partners
1 round
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Biotechnology company using AI to learn from life's chemistry and discover medicines 4X faster.
Biopharmaceutical company pioneering Helicon peptide drugs to target previously undruggable prote...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/kallyope"><img src="https://indexed.vc/api/badge/company/kallyope" alt="Kallyope on Indexed.vc" width="260" height="76" /></a>